Bradford J Shafer Insider Trading
Get free email notifications about insider trading for Bradford J Shafer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bradford J Shafer. Bradford J Shafer is a Sr VP, Gen. Counsel, Secretary in Innoviva, Inc. ($THRX) and a EVP, Gen. Counsel, Secretary in Theravance Biopharma, Inc. ($TBPH) and a Sr VP, Gen. Counsel, Secretary in Theravance Biopharma, Inc. ($TBPH).
Over the past year Bradford J Shafer has been an insider in 1 company. The total value of shares held by Bradford J Shafer in this company amounts to $3,904,744.
Bradford J Shafer ranks 7,455 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which Bradford J Shafer is an Insider
Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bradford J Shafer: Sr VP, Gen. Counsel, Secretary
Holdings: 412,398 shares
Latest Transaction: Jun 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bradford J Shafer: EVP, Gen. Counsel, Secretary, Sr VP, Gen. Counsel, Secretary
Holdings: 127,606 shares
Current Value: $3,904,744
Latest Transaction: Aug 09 2018
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: STRONG SELL
Last 3 months trend: SELL View transactions
Last 3 Months Overview:
Buy: 4x
Sell: 19x
Shares Bought: 166,750
Shares Sold: 209,061
Share Difference: -42,311
Value Difference: +$5,958,367
Latest Insider Trading Transactions of Bradford J Shafer
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 09 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 27.85 | 25,355 | 706,182 | 98,124 | 123.5 K to 98.1 K (-20.53 %) |
| Aug 09 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 28.03 | 4,127 | 115,686 | 123,479 | 127.6 K to 123.5 K (-3.23 %) |
| Aug 09 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 28.99 | 1,818 | 52,707 | 127,606 | 129.4 K to 127.6 K (-1.40 %) |
| Jun 08 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 23.66 | 3,900 | 92,260 | 129,424 | 133.3 K to 129.4 K (-2.93 %) |
| Jun 08 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 24.09 | 10,140 | 244,268 | 133,324 | 143.5 K to 133.3 K (-7.07 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 24.31 | 21,812 | 530,250 | 143,464 | 165.3 K to 143.5 K (-13.20 %) |
| May 16 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 33,750 | 0 | 165,276 | 131.5 K to 165.3 K (+25.66 %) |